Overview

Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony

Status:
NOT_YET_RECRUITING

Trial end date:
2026-08-01

Target enrollment:

Participant gender:

Summary

This research study is being done to learn what effect a single dose of calcium gluconate will have on blood loss at the time of cesarean delivery in pregnancy patients at high risk for uterine atony.

Phase:

PHASE2

Details

Lead Sponsor:

University of Michigan

Treatments:

Calcium Gluconate
Sodium Chloride